CA-NETAPP
16.3.2021 15:02:14 CET | Business Wire | Press release
Less than a year after joining global software leader NetApp (NASDAQ: NTAP) as its President, César Cernuda has announced changes to the go-to-market (GTM) model and global sales organization that will help steer the company into its cloud-led future.
Cernuda is instituting a customer- and partner-centric strategic and operational evolution that will allow NetApp to move to a customer engagement model focused on driving deeper specialization and delivering hybrid cloud expertise powered by digitization. The changes will see the company ramp up its efforts to drive consistency and simplicity across its global sales organization and more aggressively address key markets and segments while reaching new customers and partners.
“With today’s relentless pace of change, speed is the new scale. And that’s what organizations are demanding as they try to put their data to work to keep innovating and stay ahead of the digital curve,” said César Cernuda. “We are implementing these changes to better serve their needs. We will soon deliver a personalized, data-driven engagement model that allows our current and future customers to move at warp speed and aligns with the new way they want to engage with their solution partners.”
The evolution of NetApp’s sales organization will also result in changes and additions to the sales leadership team, effective May 1, 2021:
- NetApp veteran and former SVP, Globals, Verticals, and Pathways, Rick Scurfield will serve in the company’s newly established role of Chief Commercial Officer . Scurfield will be responsible for building a new GTM motion and strategy including direct sales and channel coverage and will drive the transformation of NetApp’s digital and virtual sales teams and Sales Operations to better enable NetApp’s sales force and worldwide partnerships. Scurfield has led winning sales organizations for more than 20 years, most recently growing and leading sales teams supporting NetApp’s largest global accounts, vertical segments, global pathways, and the U.S. Public Sector.
- Max Long , former SVP, Chief Customer Officer at Adobe, will be joining NetApp as the company’s new SVP, North America . Leveraging his 30+ years of experience building high-performance sales teams and leading business transformations. Long will continue the focus on aligning NetApp’s business objectives in the U.S. and Canada driven by our customer’s business requirements. He will lead direct sales, channel sales, and demand generation teams.
- Alex Wallner, also a NetApp veteran who most recently served as SVP, Worldwide Enterprise and Commercial Field Operations, will take on the newly created role of SVP, International . Wallner will lead the execution of all GTM activities for the EMEA, APAC and Latin America regions. Focusing on increasing the footprint of NetApp as the partner-of-choice for our international customers, he and his team will help customers address their data challenges with hybrid multi-cloud solutions including NetApp’s data center architectures and superior cloud software portfolio.
“Rick’s and Alex’s proven leadership and in-depth knowledge of our industry, our customers and our partners combined with Max’s track record of leading enterprise sales teams to success at scale will be instrumental in helping organizations everywhere unlock the best of today’s hybrid multi-cloud world, wherever they are on their digital transformation journey—on premises or in any cloud,” added Cernuda.
The evolution of the NetApp data-driven GTM model and cloud-led sales organization is expected to be a continuous process starting in Q1 FY22.
About NetApp
NetApp is a global cloud-led, data-centric software company that empowers organizations to lead with data in the age of accelerated digital transformation. The company provides systems, software and cloud services that enable them to run their applications optimally from data center to cloud, whether they are developing in the cloud, moving to the cloud, or creating their own cloudlike experiences on premises. With solutions that perform across diverse environments, NetApp helps organizations build their own data fabric and securely deliver the right data, services and applications to the right people—anytime, anywhere. Learn more at www.netapp.com or follow us on Twitter , LinkedIn , Facebook , and Instagram .
NETAPP, the NETAPP logo, and the marks listed at www.netapp.com/TM are trademarks of NetApp, Inc.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210316005711/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Samsung Bioepis Announces Positive Preliminary Phase 1 and Phase 3 Data for SB27, a Proposed Biosimilar to Keytruda (Pembrolizumab)29.6.2026 09:19:00 CEST | Press release
Phase 1 study demonstrated pharmacokinetic (PK) equivalence between SB27 and Keytruda; Phase 3 study demonstrated equivalent objective response rate (ORR) at Week 24Phase 1 and Phase 3 studies expected to be completed within 2026 Samsung Bioepis Co., Ltd. announced today that the Phase 1 and Phase 3 studies on SB27, a proposed biosimilar to Keytruda1 (pembrolizumab), have met their primary endpoints. “We are excited to announce preliminary results from the Phase 1 and Phase 3 studies for SB27, our pembrolizumab biosimilar candidate. These topline positive results reinforce our scientific expertise and leadership in biosimilar development,” said Donghoon Shin, Executive Vice President and Head of Clinical Sciences Division at Samsung Bioepis. “We are on track to complete both Phase 1 and Phase 3 studies within this year. Leveraging our robust quality management system, we remain committed to advancing our biosimilar portfolio to broaden access to life-saving biologic medicines for patie
IQM Named a Major Player in the IDC MarketScape: Worldwide Quantum Computing 2026 Vendor Assessment29.6.2026 09:00:00 CEST | Press release
IQM today announced it has been named a Major Player in the IDC MarketScape: Worldwide Quantum Computing 2026 Vendor Assessment. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260629748732/en/ IQM named a major player in the IDC MarketScape IQM believes this recognition comes as institutions worldwide move quantum computing out of shared cloud access and into infrastructure they own and operate themselves. IQM calls this Production Quantum: full-stack, open-architecture superconducting systems deployed on premises, inside customers' own data centers and HPC environments, where organizations own the hardware, build internal expertise, and run quantum processors alongside their existing classical infrastructure. According to the IDC MarketScape, "For institutions building long-term quantum programs, this means the workflows and intellectual property developed on IQM hardware remain portable." The report further advises: "Consi
Zambon Announces Positive CHMP Opinion for Hopledo® (IPX203) for Adults with Parkinson’s Disease and Moderate to Severe Motor Fluctuations29.6.2026 09:00:00 CEST | Press release
Positive CHMP opinion is based on data from the Phase 3 RISE-PD trial, which demonstrated significantly more “Good ON” time with fewer daily doses compared with immediate-release levodopa/carbidopa More than one million people are living with Parkinson’s disease in the European Union, and over 80% experience motor fluctuations during the course of their disease, highlighting the need for additional treatment options Hopledo® contains a unique formulation combining immediate-release granules and extended-release pellets, providing both a rapid onset of action and a longer duration of effect, sustaining the levodopa therapeutic effect for a longer period of time If approved, Zambon expects to make Hopledo® progressively available to patients with Parkinson’s disease across Europe starting October 2026 Zambon today announced that the Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the granting of a marketing authorization by the European M
Enhertu® Approved in the EU as First Tumor Agnostic HER2 Directed Therapy and Antibody Drug Conjugate for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors29.6.2026 08:30:00 CEST | Press release
Approval based on three phase 2 trials of Daiichi Sankyo and AstraZeneca’s Enhertu that demonstrated clinically meaningful responses across a broad range of tumors Enhertu now approved for six indications in the EU Enhertu® (trastuzumab deruxtecan) has been approved in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The approval by the European Commission follows the positive opinion of the Committee for Medicinal Products for Human Use of the European Medicines Agency and is based on results from subgroups of patients with HER2 positive (IHC 3+) tumors across thr
Beerenberg Prevails in Patent Case Against Aspen Aerogels29.6.2026 07:00:00 CEST | Press release
The ruling confirms that Beerenberg did not infringe Aspen Aerogels’ patents. The Korean Patent Court has invalidated three of Aspen Aerogels’ patents related to improved hydrophobic aerogel material. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260628192007/en/ Beerenberg delivers high-end insulation solutions built for performance, reliability, and long-term value. (Photo: Beerenberg) The ruling confirms the conclusion of the Intellectual Property Trial and Appeal Board (IPTAB) that the patents did not meet the necessary requirements for patentability. Beerenberg, which specializes in high-end insulation products, welcomes the court’s decision. “We are pleased that the case has now been concluded and that any uncertainty regarding the infringement claims has been removed,” says CEO Arild Apelthun. About Beerenberg Beerenberg has delivered cost-efficient solutions to a wide range of industrial enterprises for 49 years. Th
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom